Karyopharm Therapeutics Inc. Financial Ratios — KPTI Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-372.3	-42.56	-40.03	-54.24	-55.37	-71.52	-68.42	-62.75	-64.56	-40.13	-49.83	-47.81	-37.75	-143.71
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	94.11	97.5	98.38	96.68	96.62	95.86	95.93
EBITDA Margin (%)	-6,728.95	-2,487.07	-8,735.4	-32,979.48	-47,376.8	-71,438.31	-8,088.79	-590.55	-460.47	-158.1	-46.46	-90.14	-88.34	-82.01	-61.9
Operating Margin (%)	-6,783.55	-2,506.31	-8,772.61	-33,120.52	-47,630.4	-71,903.9	-8,133.21	-592.97	-462.85	-159	-46.84	-90.53	-88.71	-82.24	-62.1
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,063.64	-8,032.46	-588.02	-487.98	-181.31	-59.01	-105	-97.77	-52.58	-134.18
Profit Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,153.9	-8,036.39	-588.1	-488.08	-181.59	-59.14	-105.23	-97.99	-52.62	-134.21
Net Income to Common Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,153.9	-8,036.39	-588.1	-488.08	-181.59	-59.14	-105.23	-97.99	-52.62	-134.21
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	103	125	131	181	179	177	195	234
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	3	3	25	22
LT Debt	- -	- -	- -	- -	- -	- -	- -	103	123	129	178	176	174	170	212
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.66	-0.77	-1.85	-1.26	-1.37	-1.63	-2.58
Net Debt/EBITDA	0.64	0.02	4.61	1.99	0.49	0.45	0.53	0.09	0.1	-0.19	0.22	-0.25	-0.92	-1.05	-1.84
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.66	-0.76	-1.84	-1.26	-1.37	-1.63	-2.58
Net Debt/EBIT	0.63	0.02	4.59	1.99	0.49	0.45	0.53	0.09	0.1	-0.19	0.22	-0.25	-0.92	-1.05	-1.83
EBITDA to Interest Expense	- -	- -	- -	-75,523	- -	- -	- -	-71.86	-12.03	-6.3	-3.74	-5.66	-5.42	-3.18	-1.97
EBITDA-CapEx/Interest Expense	- -	- -	- -	-78,357	- -	- -	- -	-72.81	-12.05	-6.3	-3.96	-5.67	-5.42	-3.19	-1.97
EBIT to Interest Expense	- -	- -	- -	-75,846	- -	- -	- -	-72.16	-12.1	-6.33	-3.77	-5.69	-5.44	-3.19	-1.98
Interest Expense	- -	- -	- -	- -	- -	- -	- -	2	16	27	26	25	24	37	46
Common Equity/Total Assets	-176.27	-2,183.22	-39.54	-62.79	-119.07	-202.95	-274.74	-197.47	-296.08	-341.67	-386.05	-375.22	-618.47	-950.9	-1,622.9
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	247.24	255.63	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-17.98	-16.44	-13.77	-17.86	-15.13	-13.26	-12.39	-13.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	41.72	41.28	58.39	49.19	72.25	103.19	195.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	250.54	259.43	-226.65	-1,075.13	-129.96	-104.57	-79.75
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-17.98	-16.66	-13.97	-18.09	-15.37	-13.51	-14.21	-15.31
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	42.28	41.89	59.15	50	73.62	118.31	215.47
Net Debt to Equity	51.47	1.4	-100.67	-72.83	-29.42	-30.61	-53.29	-8.38	-38.17	63.33	26.57	-209.64	-87.14	-67.14	-56.79
Net Debt/Capital (%)	33.84	1.35	71.37	52.12	18.53	11.95	12.23	2.23	2.17	-3.12	1.78	-2.69	-8.71	-8.73	-10.49
EBITDA	-10	-16	-34	-76	-118	-110	-130	-179	-188	-171	-97	-142	-129	-119	-90
EBITDA-CapEx	-11	-16	-34	-78	-120	-110	-130	-182	-189	-171	-103	-142	-129	-119	-90
Operating Income (Loss)	-10	-16	-34	-76	-119	-111	-131	-180	-189	-172	-98	-142	-130	-119	-91

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.08	0.2	47.38	16.72	11.61	7.86	2.96	7	5.65	4.14	3.1	4.22	2.76	1.18	0.69
Current Ratio	3.24	0.49	47.98	16.89	11.74	7.99	3	7.13	6.01	4.59	3.74	5.31	3.37	1.7	1.12
Quick Ratio	3.08	0.2	47.38	16.72	11.61	7.86	2.96	7	5.82	4.35	3.41	4.93	3.14	1.51	0.98
CFO/Avg Current Liab	- -	-7.66	-11.6	-6.6	-6.86	-5.34	-2.24	-3.3	-4.09	-3.01	-1.6	-2.14	-1.37	-1.58	-0.82
Common Equity/Total Assets	-176.27	-2,183.22	-39.54	-62.79	-119.07	-202.95	-274.74	-197.47	-296.08	-341.67	-386.05	-375.22	-618.47	-950.9	-1,622.9
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	247.24	255.63	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-17.98	-16.44	-13.77	-17.86	-15.13	-13.26	-12.39	-13.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	41.72	41.28	58.39	49.19	72.25	103.19	195.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	250.54	259.43	-226.65	-1,075.13	-129.96	-104.57	-79.75
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-17.98	-16.66	-13.97	-18.09	-15.37	-13.51	-14.21	-15.31
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	42.28	41.89	59.15	50	73.62	118.31	215.47
CFO/Total Liabilities	-43.01	-53.13	-920.11	-379.88	-550.59	-465.17	-145.03	-100.69	-77.83	-61.04	-27.82	-39.9	-24.62	-36.38	-18.78
CFO/CapEx	-22.74	-128.17	-531.4	-18.15	-66.4	-1,205.59	-1,188.98	-67.34	-926.32	-1,105.06	-18.75	-1,267.41	- -	-897.79	- -
Altman's Z-Score	-6.37	-70.97	25.24	50.63	13.98	7.55	-0.37	-1.38	-2.28	-2.87	-4.23	-4.73	-8.85	-14.22	-23.89

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	10.4	10.42	11.86	4.51	3.94	5.03	5.13
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	35.09	35.02	30.77	80.85	92.54	72.54	71.15
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	13.91	1.81	1.01	1.25	1.36	1.54	1.36
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	26.23	201.73	362.1	291.62	268.36	236.43	269.26
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	1.04	1.84	1.61	2.44	1.28	1.87	1.15
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	352.47	198.26	227.11	149.81	286.1	194.99	316.8
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	-291.15	38.49	165.76	222.66	74.8	113.98	23.6
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	8.85	-166.7	-331.33	-210.78	-175.82	-163.89	-198.11
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4	4	3	5	4
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	2	4	3
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	139	1,164	472	352	440	532	1,186	1,114	483	278	99	82	80
- Cash & Cash Equivalents	7	- -	156	151	58	50	69	118	129	86	190	135	52	62	61
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	103	125	131	181	179	177	195	234
Enterprise Value	-7	- -	-17	958	296	223	294	306	1,049	996	435	179	84	168	250
Total Capital	-13	-29	-63	-138	-257	-366	-495	-571	-749	-938	-998	-1,165	-1,310	-1,369	-1,526
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-17.98	-16.66	-13.97	-18.09	-15.37	-13.51	-14.21	-15.31
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.34	0.12	0.13	0.42	1	2.1	1.16	0.93
EV/Sales	- -	- -	4,982.62	4,185.32	1,183.88	1,446.68	183	10.09	25.66	9.21	2.07	1.14	0.58	1.16	1.71
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	139	1,164	472	352	440	532	1,186	1,114	483	278	99	86	80
Diluted Enterprise Value	-7	- -	-17	1,014	413	303	371	516	1,182	1,159	473	322	224	218	254
EV per Share	- -	- -	317.79	461.74	124.64	89.06	95.98	80.84	254.02	207.31	86.72	32.88	11.09	20.7	22.89
TTM Sales	- -	1	- -	- -	- -	- -	2	30	41	108	210	157	146	145	146
TTM EBITDA	-10	-16	-34	-76	-118	-110	-130	-179	-188	-171	-97	-142	-129	-119	-90
TTM Operating Income	-10	-16	-34	-76	-119	-111	-131	-180	-189	-172	-98	-142	-130	-119	-91
TTM Cash Flow to Firm	-9	-16	-30	-51	-94	-84	-74	-157	-175	-133	-81	-125	-69	-90	-30
TTM Free Cash Flow to Firm	-8	-15	-30	-49	-93	-84	-74	-154	-175	-133	-75	-124	-69	-90	-30

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-4.6	-23.95	-5.09	-4.18	-5.98	-3.39	-6.22	-6.96	-4.76	-1.86	-1.07	-0.67	-1.07
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-7	- -	-17	958	296	223	294	306	1,049	996	435	179	84	168	250
Low Price	- -	- -	232.2	316.65	149.85	72.45	112.05	120	58.8	200.7	66.3	36.75	9.26	8.71	3.51
EV/Sales	- -	- -	4,982.62	4,185.32	1,183.88	1,446.68	183	10.09	25.66	9.21	2.07	1.14	0.58	1.16	1.71
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-3.29	-14.41	-6.73	-2.83	-3.63	-4.73	-2.82	-6.4	-5.61	-2.97	-1.7	-1.55	-0.35
Price/Earnings High	- -	- -	-4.59	-20.12	-11.58	-4.78	-5.2	-6.91	-6.2	-10.86	-10.9	-7.29	-3.89	-3.11	-0.69
Price/Earnings Low	- -	- -	-2.77	-8.67	-3.01	-1.65	-2.66	-2.55	-1.22	-4.91	-2.68	-1.21	-0.49	-0.93	-0.2
Price/Book Value	- -	- -	-2.22	-8.42	-1.84	-0.96	-0.89	-0.79	-1.36	-1.04	-0.41	-0.21	-0.07	-0.05	-0.05
Price/Book Value Average	- -	- -	-1.78	-7.89	-3.1	-0.85	-0.94	-1.25	-0.64	-1.17	-0.59	-0.36	-0.16	-0.08	-0.04
Price/Book Value High	- -	- -	-2.49	-11.02	-5.34	-1.43	-1.35	-1.83	-1.42	-1.99	-1.15	-0.9	-0.37	-0.15	-0.08
Price/Book Value Low	- -	- -	-1.5	-4.75	-1.39	-0.5	-0.69	-0.67	-0.28	-0.9	-0.28	-0.15	-0.05	-0.05	-0.02
Price/Tangible Book Value	- -	- -	0.9	5.63	2.38	2.17	3.4	2.9	23.84	22.04	-6.06	-16.71	-0.73	-0.44	-0.27
Price/Tangible Book Value Average	- -	- -	0.72	5.28	4.01	1.91	3.61	4.61	11.31	24.84	-8.74	-29.44	-1.79	-0.64	-0.23
Price/Tangible Book Value High	- -	- -	1	7.37	6.9	3.23	5.18	6.73	24.87	42.16	-16.97	-72.35	-4.08	-1.28	-0.46
Price/Tangible Book Value Low	- -	- -	0.61	3.18	1.79	1.12	2.65	2.48	4.88	19.07	-4.17	-12.04	-0.52	-0.38	-0.13
Price/Sales	- -	- -	359.04	5,083.68	1,886.41	2,287.93	274.25	17.53	29.01	10.3	2.3	1.77	0.68	0.57	0.55
Price/Sales Average	- -	- -	288.39	4,768.91	3,181.92	2,012.47	291.53	27.84	13.77	11.62	3.32	3.12	1.67	0.82	0.46
Price/Sales High	- -	- -	402.32	6,656.78	5,475.43	3,401.44	418.1	40.61	30.27	19.72	6.45	7.67	3.81	1.64	0.93
Price/Sales Low	- -	- -	242.71	2,870.19	1,423.36	1,176.86	213.63	14.98	5.94	8.92	1.58	1.28	0.48	0.49	0.26
Price/Cash Flow	- -	- -	-4.59	-22.63	-5.02	-4.18	-5.97	-3.34	-6.22	-6.95	-4.51	-1.86	-1.07	-0.65	-1.07
Price/Cash Flow Average	- -	- -	-3.68	-21.23	-8.46	-3.67	-6.35	-5.31	-2.95	-7.84	-6.5	-3.28	-2.63	-0.93	-0.9
Price/Cash Flow High	- -	- -	-5.14	-29.63	-14.56	-6.21	-9.1	-7.74	-6.49	-13.3	-12.63	-8.06	-6	-1.86	-1.81
Price/Cash Flow Low	- -	- -	-3.1	-12.78	-3.78	-2.15	-4.65	-2.86	-1.27	-6.02	-3.1	-1.34	-0.76	-0.56	-0.51
Price/Free Cash Flow Average	- -	- -	-3.69	-22.46	-8.59	-3.68	-6.35	-5.39	-2.95	-7.84	-6.87	-3.28	-2.63	-0.97	-0.9
Price/Free Cash Flow High	- -	- -	-5.15	-31.36	-14.78	-6.21	-9.11	-7.86	-6.49	-13.31	-13.34	-8.06	-6	-1.94	-1.81
Price/Free Cash Flow Low	- -	- -	-3.11	-13.52	-3.84	-2.15	-4.66	-2.9	-1.27	-6.02	-3.28	-1.34	-0.76	-0.58	-0.51
EV/Sales Average	- -	- -	3,922.88	4,111.23	2,948.49	1,689.99	248.54	27.33	13.67	12.04	3.27	3.4	2.52	1.73	1.65
EV/Sales High	- -	- -	5,631.72	5,999.1	5,242	3,078.95	375.11	40.11	30.17	20.13	6.4	7.95	4.66	2.55	2.12
EV/Sales Low	- -	- -	3,237.57	2,212.51	1,189.92	854.37	170.64	14.47	5.84	9.34	1.54	1.56	1.34	1.4	1.45
EV/EBITDA Average	0.64	0.02	1.31	-12.47	-6.22	-2.37	-3.07	-4.63	-2.97	-7.61	-7.04	-3.77	-2.85	-2.11	-2.67
EV/EBITDA High	0.64	0.02	0.01	-18.19	-11.06	-4.31	-4.64	-6.79	-6.55	-12.74	-13.77	-8.82	-5.28	-3.1	-3.42
EV/EBITDA Low	0.64	0.02	1.84	-6.71	-2.51	-1.2	-2.11	-2.45	-1.27	-5.91	-3.31	-1.73	-1.51	-1.7	-2.34
EV/EBIT Average	0.63	0.02	1.31	-12.41	-6.19	-2.35	-3.06	-4.61	-2.95	-7.57	-6.98	-3.76	-2.84	-2.1	-2.66
EV/EBIT High	0.63	0.02	0.01	-18.11	-11.01	-4.28	-4.61	-6.76	-6.52	-12.66	-13.66	-8.78	-5.26	-3.1	-3.41
EV/EBIT Low	0.63	0.02	1.83	-6.68	-2.5	-1.19	-2.1	-2.44	-1.26	-5.87	-3.28	-1.72	-1.51	-1.7	-2.33
Last Price	- -	- -	343.5	560.85	198.6	140.85	143.85	140.4	287.25	231.9	96.3	51	12.98	10.14	7.36
High Price	- -	- -	384.9	734.4	576.45	209.4	219.3	325.35	299.7	443.7	269.7	220.8	73.05	29.25	12.45
Enterprise Value Average	-7	- -	-44	941	737	260	399	829	559	1,301	686	534	368	251	241
Enterprise Value High	-7	- -	- -	1,374	1,310	474	602	1,217	1,234	2,176	1,343	1,249	681	370	309
Enterprise Value Low	-7	- -	-62	507	297	132	274	439	239	1,009	323	244	195	203	211

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	2	2	2	2	2	3	3	4	4	5	5	8	8	8	18
Diluted Weighted Avg Shares	1	1	- -	2	2	3	3	4	4	5	5	5	8	8	11
Basic Weighted Avg Shares	1	1	- -	2	2	3	3	4	4	5	5	5	8	8	11
Revenue per Share	0.23	0.97	0.96	0.11	0.11	0.06	0.52	8.01	9.9	22.5	41.84	28.78	19.17	17.88	13.36
EBITDA per Share	-15.66	-24.14	-83.57	-36.38	-49.88	-43.98	-42.43	-47.31	-45.59	-35.58	-19.44	-25.94	-16.94	-14.66	-8.27
Operating Income per Share	-15.79	-24.33	-83.93	-36.54	-50.15	-44.27	-42.66	-47.5	-45.83	-35.78	-19.6	-26.05	-17.01	-14.7	-8.3
Basic EPS, GAAP	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.41	-17.93
Basic EPS from Cont Ops	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.41	-17.93
Diluted EPS, GAAP	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.04	-17.93
Diluted EPS from Cont Ops	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.04	-17.93
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-13.09	-23.75	-74.88	-24.79	-39.6	-33.74	-24.09	-42.02	-46.2	-33.36	-21.36	-27.4	-12.17	-15.69	-6.89
Free Cash Flow per Basic Share	-13.66	-23.93	-75.02	-26.15	-40.19	-33.76	-24.11	-42.64	-46.25	-33.39	-22.5	-27.42	-12.17	-15.71	-6.89
Cash & Equivalents per Share	9.97	0.6	385.59	99.11	73.96	51.79	47.87	86.67	63.42	51.89	45.59	50.93	25.14	13.38	5.83
Book Value per Share	-19.5	-43.82	-154.67	-66.65	-108.03	-146.35	-161.88	-177.93	-211.44	-222.7	-235.04	-246.23	-195.25	-192.44	-160.9
Tangible Book Value per Share	-19.37	-42.68	383.02	99.63	83.54	64.86	42.31	48.37	12.05	10.52	-15.89	-3.05	-17.88	-22.9	-26.79

Karyopharm Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)